Scientists test DNA-Guided drugs to fight rare cancer
NCT ID NCT02069730
Summary
This study tested a personalized approach to treat advanced salivary gland cancer. First, researchers analyzed the genetic makeup of each patient's tumor. Then, patients received either a drug specifically matched to their tumor's genetic changes or a standard drug called Selinexor if no match was found.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SALIVARY GLAND CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.